Instituto de Investigaciones Biomédicas Alberto Sols-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2024

  1. Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy

    Behavioral and Brain Functions , Vol. 20, Núm. 1